SymbolBIO
NameBIO-RAD LABORATORIES, INC.
SectorINDUSTRIALS
RegionNorth America
IndustryBiotechnology: Laboratory Analytical Instruments
Address1000 ALFRED NOBEL DRIVE, HERCULES, California, 94547, United States
Telephone+1 510 724-7000
Fax
Email
Websitehttps://www.bio-rad.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000012208
Description

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Additional info from NASDAQ:
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

2026-07-23 13:00

Bio-Rad - Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026

Read more
2026-07-23 13:00

Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026

Read more
2026-05-28 19:04

📋 Alles Institute for Medical Research Corp (Director) plans to sell 700 shares of BIO-RAD LABORATORIES, INC. (at $313.28 each, total $219K) Filed: May 28, 2026 | ID: 000001

Read more
2026-05-13 19:38

ENGELHARDT EVA ANETTE 🔴 sold 550 shares of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $246.54 Transaction Date: May 11, 2026 | Filing ID: 000002

Read more
2026-05-13 17:29

New Form SD - BIO-RAD LABORATORIES, INC. <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0000012208-26-000040 <b>Size:</b> 34 KB

Read more
2026-05-11 21:03

📋 EVA ENGELHARDT (Officer) plans to sell 550 shares of BIO-RAD LABORATORIES, INC. (at $246.54 each, total $136K) Filed: May 11, 2026 | ID: 004354

Read more
2026-05-08 13:00

Bio-Rad - Bio-Rad to Participate in Upcoming Investor Conferences

Read more
2026-05-08 13:00

Bio-Rad to Participate in Upcoming Investor Conferences

Read more
2026-04-30 20:19

BIO-RAD LABORATORIES, INC. (BIO) Files Form 10-Q

Read more
2026-04-30 20:15

Bio-Rad - Bio-Rad Reports First-Quarter 2026 Financial Results

Read more